Pembrolizumab enhances the anti-pancreatic cancer activity of anlotinib
Kang Mafei,
Xu Shengyuan,
Shi Jieqiong
Affiliations
Kang Mafei
Corresponding author.; Department of Medical Oncology, The Affiliated Hospital of Guilin Medical University, China
Xu Shengyuan
Department of Medical Oncology, The Affiliated Hospital of Guilin Medical University, China
Shi Jieqiong
Corresponding author. Department of Medical Oncology, The Affiliated Hospital of Guilin Medical University, 541001, Guilin, Guangxi. No.15 Lequn Road, Guilin, China.; Department of Medical Oncology, The Affiliated Hospital of Guilin Medical University, China
